David E. Lazar - Jun 21, 2023 Form 4/A - Amendment Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Signature
/s/ David E. Lazar
Stock symbol
TTNP
Transactions as of
Jun 21, 2023
Transactions value $
-$4,610,001
Form type
4/A - Amendment
Date filed
6/28/2023, 04:14 PM
Date Of Original Report
Jun 23, 2023
Previous filing
Jan 26, 2023
Next filing
Jul 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTNP Common Stock, par value $0.001 Sale -$4.17M -3.39M -100% $1.23 0 Jun 21, 2023 Direct F1, F2, F3, F4
transaction TTNP Common Stock, par value $0.001 Sale -$442K -359K -100% $1.23 0 Jun 21, 2023 By Activist Investing LLC F1, F2, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

David E. Lazar is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These Shares were sold pursuant to a Share Transfer Agreement dated June 21, 2023. As consideration for the transfer, Mr. Lazar received $4,600,000.
F2 Prior to the filing of the Reporting Persons's Form 4 on June 23, 2023, the Reporting Person contacted the Issuer and advised the Issuer of his obligation to disgorge the "short-swing profit" realized by the Reporting Person, and that he was making preparation for payment of such disgorgement. Due to a ministerial error, such informaton was inadvertently excluded from the Form 4 filed by the Reporting Person on June 23, 2023.
F3 This Form 4 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
F4 Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
F5 Securities of the Issuer beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.